# BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome

Study · id `cardio:ct-nct04408261` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04408261](<https://clinicaltrials.gov/study/NCT04408261>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04408261

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 432 participants.

## Technical summary

Registry record NCT04408261. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-22 (actual); primary completion 2022-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 432 participants (planned count; ClinicalTrials.gov record NCT04408261, source copy `cardio:ctgov-nct04408261-2021-04-01`, retrieved 2026-11-18)
- Started: 2020-07-22 (actual) (ClinicalTrials.gov record NCT04408261, source copy `cardio:ctgov-nct04408261-2021-04-01`, retrieved 2026-11-18)
- Primary completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT04408261, source copy `cardio:ctgov-nct04408261-2021-04-01`, retrieved 2026-11-18)
- Completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT04408261, source copy `cardio:ctgov-nct04408261-2021-04-01`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT04408261, source copy `cardio:ctgov-nct04408261-2021-04-01`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04408261-2021-04-01`, retrieved 2026-11-18)

## The registry's words

- Brief title: BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome
- Acronym: BOSS
- Condition: Stroke, Ischemic
- Condition: Coronary Artery Disease
- Condition: Angina Pectoris, Stable
- Condition: Diabetic Peripheral Neuropathy
- Intervention (Drug): Buqitongluo Granule
- Intervention (Drug): Buqitongluo Granule Placebo
- Intervention (Other): Standard care
- Lead sponsor: Dongzhimen Hospital, Beijing
- Lead sponsor class: OTHER
- Collaborator: Affiliated Hospital of Changchun University of Chinese Medicine
- Collaborator class: OTHER
- Collaborator: Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: Chengdu University of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Collaborator class: UNKNOWN
- Collaborator: First Affiliated Hospital of Heilongjiang Chinese Medicine University
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: Hunan Academy of Traditional Chinese Medicine Affiliated Hospital
- Collaborator class: UNKNOWN
- Collaborator: The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine
- Collaborator class: UNKNOWN
- Collaborator: Shaanxi Buchang Pharmaceutical Co., Ltd
- Collaborator class: INDUSTRY
- Collaborator: Beijing Chuanglikechuang Medical Technology Development Co., Ltd.
- Collaborator class: UNKNOWN
- Collaborator: Shanghai Youningwei Biotechnology Co., Ltd.
- Collaborator class: UNKNOWN
- Collaborator: Wuhan Zhizhi Medical Technology Co., Ltd.
- Collaborator class: UNKNOWN
- Collaborator: Wuhan Third Hospital
- Collaborator class: OTHER
- Collaborator: Rizhao Hospital of Traditional Chinese Medicine
- Collaborator class: UNKNOWN
- Collaborator: First Affiliated Hospital of Guangxi Medical University
- Collaborator class: OTHER
- Collaborator: People's Hospital of Guangxi Zhuang Autonomous Region
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Dongzhimen Hospital, Beijing (`cardio:org-dongzhimen-hospital-beijing`)
- Registry lists this organization as a collaborator: Affiliated Hospital of Shandong University of Traditional Chinese Medicine (`cardio:org-affiliated-hospital-of-shandong-university-of-traditional-d6673e`)
- Registry lists this organization as a collaborator: Chengdu University of Traditional Chinese Medicine (`cardio:org-chengdu-university-of-traditional-chinese-medicine`)
- Registry lists this organization as a collaborator: Wuhan Third Hospital (`cardio:org-wuhan-third-hospital`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Guangxi Medical University (`cardio:org-first-affiliated-hospital-of-guangxi-medical-university`)

## Provenance

Content hash: 977812b38cc9af236b4f881813a150c7c9d4285c8983232ecdbdd0eba5a4ca5b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
